Sponsor or institution
Clinical trials and research at Istituto Clinico Humanitas
As of November 12, 2026, Find a Trial lists 28 clinical trials run by Istituto Clinico Humanitas that are recruiting, at sites in 3 countries (most in Italy (28), France (1), United Kingdom (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 28Clinical trials
- 3Countries
Newest trials
All recruiting trials (28)
-
Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs
This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.
-
Photon-counting CT to visualize the urethra for prostate cancer radiotherapy planning
This pilot study tests whether photon-counting CT can show the urethra clearly without a catheter in men with prostate cancer who are planning radiotherapy.
-
Advanced respiratory monitoring to help safer ventilation in ICU patients without respiratory failure
This study tests whether using advanced respiratory monitoring in adults who are intubated for reasons other than respiratory failure can help prevent ARDS.
-
Proton Re-irradiation for Head and Neck Cancer Recurrence
This study tests whether proton therapy as a second round of radiation is safe and helpful for adults with head and neck cancer that has come back after prior treatment.
-
Fast antibiotic sensitivity tests to guide treatment for bloodstream infections
This tests whether rapid antibiotic susceptibility tests can help doctors pick the right antibiotics sooner for adults with positive blood cultures and improve recovery and antibiotic use.
-
Critical-illness–related muscle and nerve weakness in adults hospitalized outside the ICU
This project will test how often adults hospitalized with acute illness outside the ICU develop severe muscle and nerve weakness by comparing patients with organ failure to those without.
-
Adding targeted stereotactic body radiation therapy to standard systemic treatment for people with oligometastatic urothelial (bladder) carcinoma.
This study will test whether adding stereotactic body radiation therapy (SBRT) to usual systemic treatment helps people with urothelial (bladder) cancer who have up to three extracranial metastases.
-
Repeat SBRT for Inoperable Recurrent Lung Tumors
This project will try repeat stereotactic body radiotherapy (SBRT) to treat people with inoperable non-small cell lung cancer that has come back in an area previously treated with SBRT.
-
Stereotactic body radiotherapy for extracranial oligometastatic breast cancer
This project sees if stereotactic body radiotherapy (SBRT) helps control cancer and extend survival in adults with extracranial oligometastatic breast cancer.
-
Right Ventricle Response After Major Lung Resection with Minimally Invasive or Open Surgery
This study tests how the right side of the heart handles increased pressure after major lung surgery in patients with heart or lung risks, comparing minimally invasive procedures to open surgery.
-
Humanitas Proton Therapy (HU-PRO) Registry
This registry collects treatment and outcome data from adults with solid tumors who receive proton therapy to help understand safety and effectiveness.
-
Image-guided stereotactic body radiotherapy for primary kidney cancer (STONE)
This will try high-dose, focused radiation (SBRT) to treat adults with a single small primary kidney cancer who are not good candidates for surgery or who decline surgery.
-
PEEP tuning in acute respiratory failure using CT and EIT data
Researchers will look at routine CT and electrical impedance tomography data from adults on mechanical ventilation to see how different PEEP levels relate to lung information, without any new interventions.
-
Photon-counting CT to improve tumor targeting and dose accuracy in personalized radiotherapy (ANTHEM)
This project will test whether photon-counting CT can help doctors better define tumor borders and calculate radiation doses for adults receiving high-precision radiotherapy.
-
Observational study on radiation therapy and hormone treatment for high-risk prostate cancer
This study is testing whether combining a special type of radiation therapy with hormone treatment can help men with high-risk prostate cancer do better and have fewer side effects compared to regular radiation.
-
Treatment with Loncastuximab Tesirine for Lymphoma After CAR-T Therapy Failure
This study is testing if a new treatment called Loncastuximab Tesirine can help people with lymphoma who didn't get better after CAR-T therapy.
-
Monalizumab treatment for patients with blood cancers undergoing stem cell transplantation
This study is testing if a new treatment called Monalizumab can help people with blood cancers like AML or MDS who are getting stem cell transplants by improving their immune response and reducing the chances of disease returning or complications.
-
Identifying biomarkers for neurodevelopmental disorders linked to inflammation during pregnancy
This study is trying to find signs that could help predict neurodevelopmental disorders in kids whose moms had inflammation during pregnancy.
-
Validating the BREF models for estimating breathing effort in ICU patients on high-flow nasal oxygen.
This project tests whether BREF models can accurately estimate breathing effort from esophageal pressure recordings in adults in the ICU receiving high-flow nasal oxygen.
-
Comparing Early and Late Onset Colorectal Cancer Patients
This study looks at the differences between younger and older patients with colorectal cancer to see why younger patients might have a tougher time after treatment.
-
Comparing two surgical techniques for rectal cancer treatment
This study is testing a new surgical technique for rectal cancer to see if it can lead to fewer complications compared to the traditional method for patients having surgery.
-
Identifying glioblastoma pseudoprogression using imaging and biomarkers
This study is testing new imaging and blood tests to help doctors tell the difference between false signs of tumor growth and real tumor progression in patients with glioblastoma.
-
Using AI to Improve Cost-Effectiveness of Colonoscopy Screening
This study is testing whether using artificial intelligence during colonoscopies can help doctors tell the difference between harmful and harmless polyps, making screening for colon cancer more effective and affordable.
-
Observational study of SBRT for patients with rare tumors and oligometastases
This study is testing how well a special type of radiation therapy works for patients with rare tumors that have spread to a few other places in the body.
-
Understanding survival and factors affecting squamous cell carcinoma of the nasal vestibule
This study looks at how well people with squamous cell carcinoma of the nasal vestibule do after surgery and what factors might affect their survival.
-
Comparing preoperative and postoperative hypofractionated radiosurgery for large brain metastases
This study tests whether giving targeted radiation before or after surgery helps people with large brain tumors do better and have fewer side effects.
-
Omitting axillary surgery after chemotherapy for certain breast cancer patients
This study is testing if women with certain breast cancer can skip surgery on their lymph nodes after chemotherapy and still do just as well.
-
Endoscopic treatment for Zenker's diverticulum
This study is testing new, less invasive methods to treat Zenker's diverticulum and see if they can help reduce symptoms for people with this condition.
Quick answers
How many clinical trials run by Istituto Clinico Humanitas are recruiting right now?
28, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Italy (28 trials), France (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.